GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Asset Turnover

Bangkok Genomics Innovation PCL (BKK:BKGI) Asset Turnover : 0.15 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Bangkok Genomics Innovation PCL's Revenue for the three months ended in Sep. 2024 was ฿87.7 Mil. Bangkok Genomics Innovation PCL's Total Assets for the quarter that ended in Sep. 2024 was ฿587.4 Mil. Therefore, Bangkok Genomics Innovation PCL's Asset Turnover for the quarter that ended in Sep. 2024 was 0.15.

Asset Turnover is linked to ROE % through Du Pont Formula. Bangkok Genomics Innovation PCL's annualized ROE % for the quarter that ended in Sep. 2024 was 11.12%. It is also linked to ROA % through Du Pont Formula. Bangkok Genomics Innovation PCL's annualized ROA % for the quarter that ended in Sep. 2024 was 9.80%.


Bangkok Genomics Innovation PCL Asset Turnover Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Asset Turnover Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
- 1.57 2.66 1.25 0.83

Bangkok Genomics Innovation PCL Quarterly Data
Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.19 0.16 0.15 0.15

Competitive Comparison of Bangkok Genomics Innovation PCL's Asset Turnover

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL's Asset Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's Asset Turnover falls into.



Bangkok Genomics Innovation PCL Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Bangkok Genomics Innovation PCL's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=245.39/( (300.577+293.021)/ 2 )
=245.39/296.799
=0.83

Bangkok Genomics Innovation PCL's Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=87.719/( (583.379+591.322)/ 2 )
=87.719/587.3505
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Bangkok Genomics Innovation PCL  (BKK:BKGI) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Bangkok Genomics Innovation PCL's annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=57.588/517.6935
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(57.588 / 350.876)*(350.876 / 587.3505)*(587.3505/ 517.6935)
=Net Margin %*Asset Turnover*Equity Multiplier
=16.41 %*0.5974*1.1346
=ROA %*Equity Multiplier
=9.80 %*1.1346
=11.12 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Bangkok Genomics Innovation PCL's annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=57.588/587.3505
=(Net Income / Revenue)*(Revenue / Total Assets)
=(57.588 / 350.876)*(350.876 / 587.3505)
=Net Margin %*Asset Turnover
=16.41 %*0.5974
=9.80 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Bangkok Genomics Innovation PCL Asset Turnover Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL Business Description

Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.

Bangkok Genomics Innovation PCL Headlines